Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nancy Hawkins
Institution:
Canadian Critical Care Trials Group
Observed institutions:
Renewable Energy Alaska Project,
Canadian Critical Care Trials Group,
Berry Consultants, LLC (United States)
OpenAlex ID:
A5000885360
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021
·
Eugenia Abaleke
, Mustafa Abbas
, et al.
·
The Lancet
·
533
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
493
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
369
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
290
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
2021
·
Hesham Abdelhady
, Marwa Abdelrazik
, et al.
·
JAMA
·
210
PDF
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
2022
·
Simin Florescu
, Delia Stanciu
, et al.
·
JAMA
·
146
PDF
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
2022
·
Simin Florescu
, Delia Stanciu
, et al.
·
JAMA
·
136
PDF
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
129
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
2021
·
Yaseen M. Arabi
, Anthony C. Gordon
, et al.
·
Intensive Care Medicine
·
99
PDF
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
2023
·
Simin Florescu
, Delia Stanciu
, et al.
·
JAMA
·
63
PDF
Intravenous Vitamin C for Patients Hospitalized With COVID-19
2023
·
The LOVIT-COVID Investigators, on behalf of the Canadian Critical Care Trials Group, and the REMAP-CAP Investigators
, Simin Florescu
, et al.
·
JAMA
·
53
PDF
Show more works
View as search
Works count:
12
Citation count:
2,842
H-index:
12
I10-index:
12
Year
Topic
Type